首页 | 官方网站   微博 | 高级检索  
     

Survivin基因的shRNA 干扰对结肠癌SW480 细胞增殖和凋亡的影响*
引用本文:王学虎, 傅仲学, 赵 渝, 谌 伟, 吴星烨, 王春毅. Survivin基因的shRNA 干扰对结肠癌SW480 细胞增殖和凋亡的影响*[J]. 中国肿瘤临床, 2010, 37(9): 485-489. DOI: 10.3969/j.issn.1000-8179.2010.09.002
作者姓名:王学虎  傅仲学  赵渝  谌伟  吴星烨  王春毅
作者单位:作者单位:重庆医科大学附属第一医院普通外科(重庆市400016)
基金项目:国家自然科学基金,教育部高等学校博士学科点专项科研基金 
摘    要:目的:以携带shRNA 片段的腺病毒为载体,对结肠癌细胞SW480 中Survivin基因的表达进行干扰,研究其对肿瘤细胞中Survivin基因沉默效果及对细胞周期、凋亡和增殖的影响。方法:将构建好的携带Survivin-shRNA 片段腺病毒,体外转染结肠癌细胞株SW480。以EGFP为报告基因,采用流式细胞计数测定不同感染复数(MOI)下的转染效率,选取适当病毒浓度进行下一步实验。通过RT-PCR 和Western blot检测基因沉默后结肠癌细胞内Survivin mRNA和蛋白的表达水平;在Annexin V-FITC 和PI染色后通过流式细胞术检测并分析Survivin基因沉默后细胞周期和凋亡的变化;同时采用噻唑蓝(MTT)法、克隆增殖实验对细胞不同时期增殖活性进行观察,明确对细胞增殖的抑制时效性。结果:腺病毒转染后MOI 值在0~50时,剂量与转染效率成正比,确定最佳MOI 值为50并进行后续实验;shRNA 干扰后细胞内Survivin mRNA和蛋白表达水平降低,较对照细胞组差异有统计学意义(P<0.01)。 流式细胞仪检测结果显示基因沉默后细胞凋亡率升高,与对照组相比差异有统计学意义(P<0.01)。 同时基因沉默后,细胞周期也有明显变化,表现为G1/S 期细胞增多和G2/M期细胞减少,与对照细胞组相比差异有统计学意义(P<0.05)。 MTT 和单克隆平板实验均显示Survivin基因的沉默,对细胞的增殖和生长均具有明显抑制作用(P<0.05)。 结论:采用腺病毒对结肠癌进行靶向Survivin基因的shRNA 干扰,能有效降低目的基因的表达。其介导的Survivin基因的沉默,可以有效的诱导结肠癌细胞凋亡,同时Survivin基因可以通过抑制细胞G1/S 期转化来阻止细胞分裂,抑制细胞生长。

关 键 词:Survivin  RNA干扰  增殖  凋亡  结肠癌
收稿时间:2009-04-21
修稿时间:2009-09-01

Influence of the Survivin Gene on the Proliferation and Apoptosis of Colon Carcinoma Cells
WANG Xuehu, FU Zhongxue, ZHAO Yu, SHEN Wei, WU Xingye, WANG Chunyi. Influence of the Survivin Gene on the Proliferation and Apoptosis of Colon Carcinoma Cells[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 37(9): 485-489. DOI: 10.3969/j.issn.1000-8179.2010.09.002
Authors:WANG Xuehu  FU Zhongxue  ZHAO Yu  SHEN Wei  WU Xingye  WANG Chunyi
Affiliation:Department of General Surgery, First Affiliated Hospital of Chongqing Medical University, Chongqing400016, China
Abstract:Objective:To evaluate the interference effects of using a replication-defective adenovirus vector on the Sur -vivin gene in the colon carcinoma cell line SW480 and to investigate the proliferation and apoptosis of SW480 cells after Survivin gene silencing. Methods:To study the biological function of Survivin in colon cancer, RNA interference was applied to knock down survivin expression in the colon cancer cell line SW 480 by recombinant replication-defective adenovirus pro -ducing Survivin small hairpin RNA (Survivin-shRNA). The infection rates were detected at different multiplicity of infection (MOI) at 48h after transfection and the optimized one was chosen for the subsequent experiments. After Survivin gene si-lencing, expression of Survivin mRNA and protein was detected by RT-PCR and Western blot, respectively. The cell cycle and the degree of cell apoptosis were analyzed by flow cytometry (FCM) at 48h after transfection. To analyze the effect of shRNA-Survivin on the proliferation of tumor cells, we performed MTT and colony formation assays. Results: The infection rate was significantly different when the MOI was at 10-50, and the rate was dose-dependent. There was no difference be -tween MOI= 50and MOI=100 . The optimized MOI was 50and was used at this level for the following experiments. RT-PCR and Wertern blot results demonstrated that expression of Survivin protein and the Survivin gene was down-regulated in co-lon cancer cells after Survivin gene silencing. The rate of apoptosis was obviously increased after Survivin gene silencing (P<0.05). After Survivin gene silencing, the number of cells in the G1/S phase was increased and that in G2/M phase was decreased, with a significant difference (P<0.05). MTT and colony-formation assays showed that shRNA-Survivin had an obvious inhibitory effect on the growth of colon cancer cells in the experimental group (P<0.05). Conclusion:Survivin was over expressed in colon cancer SW480 cells and the replication-defective adenovirus vector carrying Survivin-shRNA can suppress expression of Survivin mRNA and protein and thus can induce cell apoptosis and block cell division by blocking cells in G1/S phase. 
Keywords:Survivin
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号